Stock STRM STREAMLINE HEALTH SOLUTIONS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Streamline Health Solutions, Inc.

Equities

STRM

US86323X1063

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.321 USD -5.59% Intraday chart for Streamline Health Solutions, Inc. -3.02% -24.47%
Apr. 25 Streamline Health Solutions, Inc. Signs Second Enterprise Client CI
Feb. 07 Streamline Health Solutions, Inc. Appoints New Directors CI

Valuation

Fiscal Period: Januar 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 23.94 32.51 56.42 63.8 120.6 18.25 - -
Enterprise Value (EV) 1 23.94 32.51 56.42 63.8 120.6 18.25 18.25 18.25
P/E ratio -4.13 x -8.46 x 185 x -8.56 x -9.39 x -0.93 x -2.79 x -
Yield - - - - - - - -
Capitalization / Revenue 1.07 x 1.57 x 4.97 x 3.67 x 4.85 x 0.8 x 0.83 x 0.78 x
EV / Revenue 1.07 x 1.57 x 4.97 x 3.67 x 4.85 x 0.8 x 0.83 x 0.78 x
EV / EBITDA 8.29 x 10.4 x -29.8 x -31.3 x -32.1 x -9.78 x 11.9 x -
EV / FCF - - -25.4 x -18 x -16.9 x -1.02 x -8.82 x 10.3 x
FCF Yield - - -3.93% -5.56% -5.93% -97.9% -11.3% 9.75%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 19,306 29,559 30,497 46,570 55,852 56,849 - -
Reference price 2 1.240 1.100 1.850 1.370 2.160 0.3210 0.3210 0.3210
Announcement Date 4/22/19 4/22/20 4/21/21 4/27/22 4/26/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: January 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 22.36 20.74 11.35 17.38 24.89 22.71 21.88 23.52
EBITDA 1 2.889 3.133 -1.893 -2.037 -3.757 -1.866 1.532 -
EBIT 1 -5.302 -2.141 -5.946 -10.77 -10.83 -20.56 -5.526 -0.588
Operating Margin -23.71% -10.32% -52.41% -61.95% -43.52% -90.53% -25.26% -2.5%
Earnings before Tax (EBT) 1 -5.865 -2.841 -6.059 -6.808 -11.31 -20.25 -6.708 -
Net income 1 -5.865 -2.863 0.296 -6.917 -11.38 -19.53 -6.708 -
Net margin -26.22% -13.8% 2.61% -39.8% -45.72% -86.02% -30.66% -
EPS 2 -0.3000 -0.1300 0.0100 -0.1600 -0.2300 -0.3450 -0.1150 -
Free Cash Flow 1 - - -2.22 -3.545 -7.153 -17.86 -2.07 1.779
FCF margin - - -19.57% -20.4% -28.74% -78.65% -9.46% 7.56%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 4/22/19 4/22/20 4/21/21 4/27/22 4/26/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: January 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 2.868 5.514 6.046 5.935 5.992 6.217 6.745 5.332 5.77 6.133 5.489 4.519 5.271 5.976 6.112
EBITDA 1 -0.764 -0.298 -0.3 -1.693 -1.096 -1.172 -0.207 -1.337 -0.893 0.413 -0.0575 -0.332 0.267 0.765 0.8325
EBIT 1 -2.385 -3.82 -2.107 -3.177 -2.656 -3.162 -1.836 -2.996 -2.598 -12.95 -1.986 -2.103 -1.466 -1.031 -0.926
Operating Margin -83.16% -69.28% -34.85% -53.53% -44.33% -50.86% -27.22% -56.19% -45.03% -211.1% -36.18% -46.54% -27.82% -17.25% -15.15%
Earnings before Tax (EBT) 1 -0.075 -4.375 0.096 -2.776 -3.27 -3.129 -2.133 -2.848 -2.507 -12.03 -2.269 -2.386 -1.75 -1.314 -1.259
Net income 1 -0.06 -4.31 -0.004 -2.787 -3.272 -3.138 -2.182 -2.901 -2.515 -11.91 -2.269 -2.386 -1.75 -1.314 -1.259
Net margin -2.09% -78.16% -0.07% -46.96% -54.61% -50.47% -32.35% -54.41% -43.59% -194.21% -41.34% -52.8% -33.19% -21.99% -20.6%
EPS 2 - -0.1000 -0.000100 -0.0600 -0.0700 -0.0700 -0.0400 -0.0500 -0.0400 -0.2100 -0.0400 -0.0400 -0.0300 -0.0250 -0.0200
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 9/8/21 12/8/21 4/27/22 6/8/22 9/7/22 12/14/22 4/26/23 6/12/23 9/13/23 12/13/23 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: January 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - -2.22 -3.55 -7.15 -17.9 -2.07 1.78
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 0.02 0.05 0.04 0.04 0.01 2.01 1.51 1.55
Capex / Sales 0.09% 0.25% 0.39% 0.24% 0.04% 8.85% 6.9% 6.58%
Announcement Date 4/22/19 4/22/20 4/21/21 4/27/22 4/26/23 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Streamline Health Solutions, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.321 USD
Average target price
1.25 USD
Spread / Average Target
+289.41%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
STREAMLINE HEALTH SOLUTIONS, INC. Stock Streamline Health Solutions, Inc.
-24.47% 18.25M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. STRM Stock
  4. Financials Streamline Health Solutions, Inc.